A Clinical Study to Evaluate Symbicort Turbuhaler Used 'as Needed' in Adults and Adolescents With Asthma.

Last updated:
2026-07-25
Language and content disclaimer

The content and search results on this site are collected from or provided by third parties. As such some of the information may only be available in the language originally submitted by the sponsor of the trial. Learn more about the information on the search portal.

Linking to Non-Government of Canada Websites

Links to websites not under the control of the Government of Canada, including those to our social media accounts, and to clinical trial records in international registries are provided solely for the convenience of our website visitors. We are not responsible for the accuracy, currency or reliability of the content of such websites. The Government of Canada does not offer any guarantee in that regard and is not responsible for the information found through these links, nor does it endorse the sites and their content.

Visitors should also be aware that information offered by non-Government of Canada sites to which this website links is not subject to the Privacy Act or the Official Languages Act and may not be accessible to persons with disabilities. The information offered may be available only in the language(s) used by the sites in question. With respect to privacy, visitors should research the privacy policies of these non-government websites before providing personal information.

View trial details

Overview

Official protocol title:

A 52-WEEK, DOUBLE-BLIND, RANDOMISED, MULTI-CENTRE, PARALLEL-GROUP, PHASE III STUDY IN PATIENTS 12 YEARS AND OLDER WITH ASTHMA, EVALUATING THE EFFICACY AND SAFETY OF SYMBICORT (BUDESONIDE/FORMOTEROL) TURBUHALER 160/4.5 µG 'AS NEEDED' COMPARED WITH TERBUTALINE TURBUHALER 0.4 MG 'AS NEEDED' AND WITH PULMICORT (BUDESONIDE) TURBUHALER 200 µG TWICE DAILY PLUS TERBUTALINE TURBUHALER 0.4 MG 'AS NEEDED'

Intervention/treatment:
SYMBICORT TURBUHALER (BUDESONIDE-FORMOTEROL)
Medical condition:
ASTHMA
Protocol code:
D589SC00001
Control number:
173114
Status:
Closed
Approved:
April 14, 2014
Date Completed:
Trial phase:
Phase 3
For more information:
ClinicalTrials.gov - NCT02149199
This is an external link. The information is not authorized by the Government of Canada.

Eligibility

Sex: ALL
Age
12 Years to 130 Years
Accepts healthy volunteers: No

Contacts and locations

Contact
Name
Stefan Ivanov
Organization
AstraZeneca AB
Phone:
000000000000
Sponsor
ASTRAZENECA CANADA INC

Locations

Alberta

Research Site
Edmonton, Alberta, T5A 4L8
Research Site
Sherwood Park, Alberta, T8L 0N2

British Columbia

Research Site
Maple Ridge, British Columbia, V2X 2L5
Research Site
North Vancouver, British Columbia, V7M 2H9
Research Site
Vancouver, British Columbia, V5Z 1M9

Newfoundland and Labrador

Research Site
Mount Pearl, Newfoundland and Labrador, A1N 1W7
Research Site
St. John's, Newfoundland and Labrador, A1A 3R5

Ontario

Research Site
Ajax, Ontario, L1S 2J5
Research Site
Burlington, Ontario, L7N 3V2
Research Site
Cornwall, Ontario, K6H 4M4
Research Site
Etobicoke, Ontario, M9W 4L6
Research Site
Hamilton, Ontario, L8N 4A6
Research Site
Kanata, Ontario, K2L 3C8
Research Site
London, Ontario, N6H 0G6
Research Site
Mississauga, Ontario, L5A 3V4
Research Site
Newmarket, Ontario, L3Y 5G8
Research Site
North York, Ontario, M3M 3E5
Research Site
Ottawa, Ontario, K2H 8T5
Research Site
Sarnia, Ontario, N7T 4X3
Research Site
Toronto, Ontario, M9C 4Z5
Research Site
Toronto, Ontario, M9V 4B4
Research Site
Windsor, Ontario, N8X 2G1

Quebec

Research Site
Lévis, Quebec, G6W 0M5
Research Site
Montreal, Quebec, H1M 1B1
Research Site
Montreal, Quebec, H3G 1L5
Research Site
Montreal, Quebec, H4J 1C5
Research Site
Pointe-Claire, Quebec, H9R 4S3
Research Site
Québec, Quebec, G1G 3Y8
Research Site
Québec, Quebec, G1V 4W2
Research Site
Québec, Quebec, G1W 4R4
Research Site
Québec, Quebec, G2J 0C4
Research Site
Saint-Charles-Borromée, Quebec, J6E 2B4
Research Site
Trois-Rivières, Quebec, G8T 7A1
Research Site
Victoriaville, Quebec, G6P 6P6

Results

See the results from the trial NCT02149199. This is an external link. The information is not authorized by the Government of Canada.

Date posted:
Did you find what you were looking for?